Three new articled published this week in PLoS Medicine, including two magazine pieces on R&D:
Diana Gibb and colleagues investigate the effect of in utero tenofovir exposure by analysing the pregnancy and infant outcomes of HIV-infected women enrolled in the DART trial.
As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.
John-Arne Røttingen and Claudia Chamas, chairs of the the Consultative Expert Working Group on Research and Development (CEWG), summarize their recent report recommending to the World Health Assembly that a global health R&D convention be developed.
This work, unless otherwise expressly stated, is licensed under a Creative Commons Attribution 3.0 Unported License.